Super early treatment for HIV acquired in utero
- PMID: 38061375
- DOI: 10.1016/S2352-3018(23)00260-6
Super early treatment for HIV acquired in utero
Conflict of interest statement
PVdP is an employee of the University of Montpellier and a recipient of research grants from the French National Agency for Research on AIDS and Viral Hepatitis–Emerging Infectious Diseases (ANRS/MIE), the Thrasher Research Fund, and the European Developing Countries Clinical Trial Partnership. PLM is supported by the South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation of South Africa, and by the South African Medical Research Council.
Comment on
-
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.Lancet HIV. 2024 Jan;11(1):e20-e30. doi: 10.1016/S2352-3018(23)00236-9. Epub 2023 Dec 4. Lancet HIV. 2024. PMID: 38061376 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
